17 oct 2014 año - FDA approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the- clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Añadido al timeline:
fecha:
17 oct 2014 año
Ahora mismo
~ 11 years ago